MIRA
INFORM REPORT
|
Report Date : |
30.10.2012 |
IDENTIFICATION DETAILS
|
Name : |
LABORATORIOS FABRA S.A. |
|
|
|
|
Registered Office : |
Carlos Villate 5271, Munro, B1605AXM |
|
|
|
|
Country : |
|
|
|
|
|
Year of Establishment : |
1988 |
|
|
|
|
Com. Reg. No.: |
30-53447579-5 |
|
|
|
|
Legal Form : |
Private Independent Company |
|
|
|
|
Line of Business : |
Medical Products Laboratory |
|
|
|
|
No. of Employees : |
201 employees |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 890000 |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Argentina |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
argentina - ECONOMIC OVERVIEW
Argentina benefits from rich natural resources, a highly literate
population, an export-oriented agricultural sector, and a diversified
industrial base. Although one of the world's wealthiest countries 100 years
ago, Argentina suffered during most of the 20th century from recurring economic
crises, persistent fiscal and current account deficits, high inflation,
mounting external debt, and capital flight. A severe depression, growing public
and external indebtedness, and a bank run culminated in 2001 in the most
serious economic, social, and political crisis in the country's turbulent
history. Interim President Adolfo RODRIGUEZ SAA declared a default - the
largest in history - on the government's foreign debt in December of that year,
and abruptly resigned only a few days after taking office. His successor,
Eduardo DUHALDE, announced an end to the peso's decade-long 1-to-1 peg to the
US dollar in early 2002. The economy bottomed out that year, with real GDP 18%
smaller than in 1998 and almost 60% of Argentines under the poverty line. Real
GDP rebounded to grow by an average 8.5% annually over the subsequent six
years, taking advantage of previously idled industrial capacity and labor, an
audacious debt restructuring and reduced debt burden, excellent international
financial conditions, and expansionary monetary and fiscal policies. Inflation
also increased, however, during the administration of President Nestor
KIRCHNER, which responded with price restraints on businesses, as well as
export taxes and restraints, and beginning in early 2007, with understating
inflation data. Cristina FERNANDEZ DE KIRCHNER succeeded her husband as
President in late 2007, and the rapid economic growth of previous years began
to slow sharply the following year as government policies held back exports and
the world economy fell into recession. The economy has rebounded strongly from
the 2009 recession, but the government's continued reliance on expansionary
fiscal and monetary policies risks exacerbating already high inflation.
|
Source : CIA |
Company name & address
Laboratorios Fabra S.A.
Carlos Villate 5271
Munro, B1605AXM
Argentina
Tel: 54-11-47561216
Fax: 54-11-47561216
Web: www.fabra.com.ar
Synthesis
Employees: 201
Company Type: Private Independent
Incorporation Date: 1988
Financials in: USD
(Millions)
Fiscal Year End: 30-Jun-2011
Reporting Currency:
Argentine Peso
Annual Sales: 21.3
Total Assets: NA
Credit Limit USD 890000
Business Description
Medical Products Laboratory
Industry
Industry Biotechnology and Drugs
ANZSIC 2006: 1841 - Human
Pharmaceutical and Medicinal Product Manufacturing
NACE 2002: 2442 - Manufacture
of pharmaceutical preparations
NAICS 2002: 325412 -
Pharmaceutical Preparation Manufacturing
UK SIC 2003: 24421 -
Manufacture of medicaments
UK SIC 2007: 2120 - Manufacture
of pharmaceutical preparations
US SIC 1987: 2834 -
Pharmaceutical Preparations
Key Executives
|
Name |
Title |
|
Guillermo Fabra |
Presidente |
|
Rodolfo Bettinotti |
Gerente de Ventas |
|
Jorge Colls |
Gerente Administrativo |
|
Sandra Paz |
Encargada de Investigación y D |
|
Norberto Torres |
Gerente de Recursos Humanos |
Registered No.(ARG): 30-53447579-5
1 - Profit & Loss Item Exchange Rate: USD 1 = ARS 3.999745
2 - Balance Sheet Item Exchange Rate: USD 1 = ARS 4.104
Corporate Overview
Location
Carlos Villate 5271
Munro, B1605AXM
Argentina
Tel: 54-11-47561216
Fax: 54-11-47561216
Web: www.fabra.com.ar
Sales ARS(mil): 85.3
Assets ARS(mil): NA
Employees: 201
Fiscal Year End: 30-Jun-2011
Industry: Biotechnology and Drugs
Incorporation Date: 1988
Company Type: Private
Independent
Quoted Status: Not
Quoted
Registered No.(ARG): 30-53447579-5
Presidente: Guillermo
Fabra
Contents
Industry Codes
Business Description
Financial Data
Industry Codes
ANZSIC 2006 Codes:
1841 - Human Pharmaceutical and Medicinal Product Manufacturing
NACE 2002 Codes:
2442 - Manufacture of pharmaceutical preparations
NAICS 2002 Codes:
325412 - Pharmaceutical Preparation Manufacturing
US SIC 1987:
2834 - Pharmaceutical Preparations
UK SIC 2003:
24421 - Manufacture of medicaments
UK SIC 2007:
2120 - Manufacture of pharmaceutical preparations
Business
Description
Medical Products Laboratory
More Business
Descriptions
Pharmaceutical preparations
|
|
|||||||||||||
Executive report
|
Executives |
|
|
|
|
|||
|
Presidente |
President |
|
|||
|
Gerente Administrativo |
Administration Executive |
|
|||
|
||||||
|
Gerente de Recursos Humanos |
Human Resources Executive |
|
|
||
|
||||||
|
Gerente de Ventas |
Sales Executive |
|
|
||
|
Encargada de Investigación y D |
Research & Development Executive |
|
|
||
|
Gerente de Comercio Exterior |
Commercial Executive |
|
|
||
|
Vicepresidente |
Other |
|
|
||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.81 |
|
UK Pound |
1 |
Rs.86.52 |
|
Euro |
1 |
Rs.69.50 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.